ArticleActa pharmacologica Sinica2025

A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth.

Qing-Yong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.